Belgian healthcare specialist Cofinimmo has grown more than it had anticipated this year – happy coincidence maybe, but in a sector with much more scope for those with the expertise. Paul Strohm reports.
You have reached premium content
Our readers look to Real Asset Insight to stay informed about the issues that matter in the real asset markets. Log in, start a free trial or subscribe below.
				
				
					
						
							45 Day Free Trial – Real Asset INSIGHT & IMPACT
							Start your trial today
						 
						
							€0.00
							30 days full access
						 
					 
				 
				
					
						
							Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.
45 DAY TRIAL MEMBERSHIP
Be part of the leading real asset community!
							Get your free trial now
						 
						
					 
				 
			 
						
				
					
						
							Real Asset INSIGHT Premium
							Taking you beyond the headlines
						 
						
							€495.00
							12 month Subscription
						 
					 
				 
				
					
						
							SUBSCRIBE NOW
Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.
Be part of the leading real asset community and subscribe now! 
							Subscribe now